Influence of DOTA Chelators on Radiochemical Purity and Biodistribution of <sup>177</sup>Lu- and <sup>90</sup>Y-Rituximab in Xenografted Mice.

Karczmarczyk, Urszula; Wojdowska, Wioletta; Mikolajczak, Renata; Maurin, Michal; Laszuk, Ewa; Garnuszek, Piotr

Influence of DOTA Chelators on Radiochemical Purity and Biodistribution of ¹⁷⁷Lu- and ⁹⁰Y-Rituximab in Xenografted Mice.

Karczmarczyk, Urszula; Wojdowska, Wioletta; Mikolajczak, Renata; Maurin, Michal; Laszuk, Ewa; Garnuszek, Piotr.

Afiliação

Karczmarczyk U; National Centre for Nuclear Research, Radioisotope Centre POLATOM, Otwock, Poland.
Wojdowska W; National Centre for Nuclear Research, Radioisotope Centre POLATOM, Otwock, Poland.
Mikolajczak R; National Centre for Nuclear Research, Radioisotope Centre POLATOM, Otwock, Poland.
Maurin M; National Centre for Nuclear Research, Radioisotope Centre POLATOM, Otwock, Poland.
Laszuk E; National Centre for Nuclear Research, Radioisotope Centre POLATOM, Otwock, Poland.
Garnuszek P; National Centre for Nuclear Research, Radioisotope Centre POLATOM, Otwock, Poland.

Iran J Pharm Res ; 17(4): 1201-1208, 2018.

Article em En | MEDLINE | ID: mdl-30568680

Palavras-chave

177Lu and 90Y; Animal study; Anti-CD20; DOTA chelator; Radiolabeling; Rituximab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Iran J Pharm Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Polônia País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google